← Back to Search

Biopsy Needle

VMCore Biopsy System for Prostate Cancer

N/A
Waitlist Available
Research Sponsored by Uro-1 Medical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day of the procedure
Awards & highlights

Study Summary

This study is evaluating whether the VMCore biopsy needle captures more tissue than standard of care needles.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day of the procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 day of the procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adverse Events
Patient Pain During use of the biopsy needles
Procedure Success
Secondary outcome measures
Mean Tissue volume for each sample taken

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: VMCore Biopsy SystemExperimental Treatment1 Intervention
The VMCore biopsy needle will used to collect up to 10 tissue samples.
Group II: Standard of Care Biopsy NeedleActive Control1 Intervention
The urologist will use his/her standard biopsy needle to collect up to 15 tissue samples.

Find a Location

Who is running the clinical trial?

Uro-1 MedicalLead Sponsor
2 Previous Clinical Trials
90 Total Patients Enrolled
Thomas LawsonStudy DirectorUro-1 Medical

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~8 spots leftby Apr 2025